Annual D&A
$5.61 M
+$442.00 K+8.55%
31 December 2023
Summary:
Poseida Therapeutics annual depreciation & amortization is currently $5.61 million, with the most recent change of +$442.00 thousand (+8.55%) on 31 December 2023. During the last 3 years, it has risen by +$3.03 million (+117.09%). PSTX annual D&A is now at all-time high.PSTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$1.32 M
-$30.00 K-2.22%
30 September 2024
Summary:
Poseida Therapeutics quarterly depreciation & amortization is currently $1.32 million, with the most recent change of -$30.00 thousand (-2.22%) on 30 September 2024. Over the past year, it has dropped by -$125.00 thousand (-8.66%). PSTX quarterly D&A is now -8.66% below its all-time high of $1.44 million, reached on 30 September 2023.PSTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$5.48 M
-$125.00 K-2.23%
30 September 2024
Summary:
Poseida Therapeutics TTM depreciation & amortization is currently $5.48 million, with the most recent change of -$125.00 thousand (-2.23%) on 30 September 2024. Over the past year, it has dropped by -$51.00 thousand (-0.92%). PSTX TTM D&A is now -3.30% below its all-time high of $5.67 million, reached on 31 March 2024.PSTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.6% | -8.7% | -0.9% |
| 3 y3 years | +117.1% | +12.8% | +24.4% |
| 5 y5 years | +714.8% | +280.1% | +579.4% |
PSTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +117.1% | -8.7% | +12.8% | -3.3% | +24.4% |
| 5 y | 5 years | at high | +714.8% | -8.7% | +280.1% | -3.3% | +579.4% |
| alltime | all time | at high | +730.5% | -8.7% | +556.2% | -3.3% | +2627.9% |
Poseida Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.32 M(-2.2%) | $5.48 M(-2.2%) |
| June 2024 | - | $1.35 M(-2.2%) | $5.61 M(-1.1%) |
| Mar 2024 | - | $1.38 M(-3.8%) | $5.67 M(+1.0%) |
| Dec 2023 | $5.61 M(+8.5%) | $1.44 M(-0.6%) | $5.61 M(+1.4%) |
| Sept 2023 | - | $1.44 M(+2.3%) | $5.53 M(+1.7%) |
| June 2023 | - | $1.41 M(+6.6%) | $5.44 M(+2.9%) |
| Mar 2023 | - | $1.32 M(-2.3%) | $5.29 M(+2.3%) |
| Dec 2022 | $5.17 M(+13.6%) | $1.35 M(+0.4%) | $5.17 M(+3.4%) |
| Sept 2022 | - | $1.35 M(+7.1%) | $5.00 M(+3.8%) |
| June 2022 | - | $1.26 M(+4.4%) | $4.82 M(+2.8%) |
| Mar 2022 | - | $1.21 M(+2.0%) | $4.69 M(+3.0%) |
| Dec 2021 | $4.55 M | $1.18 M(+1.2%) | $4.55 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $1.17 M(+3.6%) | $4.41 M(+12.3%) |
| June 2021 | - | $1.13 M(+5.2%) | $3.93 M(+21.1%) |
| Mar 2021 | - | $1.07 M(+3.1%) | $3.24 M(+25.4%) |
| Dec 2020 | $2.59 M(+116.8%) | $1.04 M(+51.4%) | $2.59 M(+33.9%) |
| Sept 2020 | - | $687.00 K(+55.1%) | $1.93 M(+21.4%) |
| June 2020 | - | $443.00 K(+6.5%) | $1.59 M(+13.1%) |
| Mar 2020 | - | $416.00 K(+7.8%) | $1.41 M(+18.0%) |
| Dec 2019 | $1.19 M(+73.1%) | $386.00 K(+11.2%) | $1.19 M(+47.8%) |
| Sept 2019 | - | $347.00 K(+34.0%) | $807.00 K(+75.4%) |
| June 2019 | - | $259.00 K(+28.9%) | $460.00 K(+128.9%) |
| Mar 2019 | - | $201.00 K | $201.00 K |
| Dec 2018 | $689.00 K(+1.9%) | - | - |
| Dec 2017 | $676.00 K | - | - |
FAQ
- What is Poseida Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Poseida Therapeutics?
- What is Poseida Therapeutics annual D&A year-on-year change?
- What is Poseida Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly D&A year-on-year change?
- What is Poseida Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Poseida Therapeutics?
- What is Poseida Therapeutics TTM D&A year-on-year change?
What is Poseida Therapeutics annual depreciation & amortization?
The current annual D&A of PSTX is $5.61 M
What is the all time high annual D&A for Poseida Therapeutics?
Poseida Therapeutics all-time high annual depreciation & amortization is $5.61 M
What is Poseida Therapeutics annual D&A year-on-year change?
Over the past year, PSTX annual depreciation & amortization has changed by +$442.00 K (+8.55%)
What is Poseida Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of PSTX is $1.32 M
What is the all time high quarterly D&A for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly depreciation & amortization is $1.44 M
What is Poseida Therapeutics quarterly D&A year-on-year change?
Over the past year, PSTX quarterly depreciation & amortization has changed by -$125.00 K (-8.66%)
What is Poseida Therapeutics TTM depreciation & amortization?
The current TTM D&A of PSTX is $5.48 M
What is the all time high TTM D&A for Poseida Therapeutics?
Poseida Therapeutics all-time high TTM depreciation & amortization is $5.67 M
What is Poseida Therapeutics TTM D&A year-on-year change?
Over the past year, PSTX TTM depreciation & amortization has changed by -$51.00 K (-0.92%)